Copyright Reports & Markets. All rights reserved.

Global Serum Cancer Biomarkers Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Serum Cancer Biomarkers

      • 1.1 Definition of Serum Cancer Biomarkers
      • 1.2 Serum Cancer Biomarkers Segment by Type
        • 1.2.1 Global Serum Cancer Biomarkers Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Hepatocellular Carcinoma Serum Biomarkers
        • 1.2.3 Lung Cancer Serum Biomarkers
        • 1.2.4 Pancreatic & Biliary Tract Cancer Serum Biomarkers
        • 1.2.5 Breast Cancer Serum Biomarkers
        • 1.2.6 Glioblastoma Serum Biomarkers
        • 1.2.7 Others
      • 1.3 Serum Cancer Biomarkers Segment by Applications
        • 1.3.1 Global Serum Cancer Biomarkers Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hospitals
        • 1.3.3 Academic & Research Institutes
        • 1.3.4 Ambulatory Surgical Centers
        • 1.3.5 Others
      • 1.4 Global Serum Cancer Biomarkers Overall Market
        • 1.4.1 Global Serum Cancer Biomarkers Revenue (2014-2025)
        • 1.4.2 Global Serum Cancer Biomarkers Production (2014-2025)
        • 1.4.3 North America Serum Cancer Biomarkers Status and Prospect (2014-2025)
        • 1.4.4 Europe Serum Cancer Biomarkers Status and Prospect (2014-2025)
        • 1.4.5 China Serum Cancer Biomarkers Status and Prospect (2014-2025)
        • 1.4.6 Japan Serum Cancer Biomarkers Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Serum Cancer Biomarkers Status and Prospect (2014-2025)
        • 1.4.8 India Serum Cancer Biomarkers Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Serum Cancer Biomarkers
      • 2.3 Manufacturing Process Analysis of Serum Cancer Biomarkers
      • 2.4 Industry Chain Structure of Serum Cancer Biomarkers

      3 Development and Manufacturing Plants Analysis of Serum Cancer Biomarkers

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Serum Cancer Biomarkers Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Serum Cancer Biomarkers
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Serum Cancer Biomarkers Production and Capacity Analysis
      • 4.2 Serum Cancer Biomarkers Revenue Analysis
      • 4.3 Serum Cancer Biomarkers Price Analysis
      • 4.4 Market Concentration Degree

      5 Serum Cancer Biomarkers Regional Market Analysis

      • 5.1 Serum Cancer Biomarkers Production by Regions
        • 5.1.1 Global Serum Cancer Biomarkers Production by Regions
        • 5.1.2 Global Serum Cancer Biomarkers Revenue by Regions
      • 5.2 Serum Cancer Biomarkers Consumption by Regions
      • 5.3 North America Serum Cancer Biomarkers Market Analysis
        • 5.3.1 North America Serum Cancer Biomarkers Production
        • 5.3.2 North America Serum Cancer Biomarkers Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Serum Cancer Biomarkers Import and Export
      • 5.4 Europe Serum Cancer Biomarkers Market Analysis
        • 5.4.1 Europe Serum Cancer Biomarkers Production
        • 5.4.2 Europe Serum Cancer Biomarkers Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Serum Cancer Biomarkers Import and Export
      • 5.5 China Serum Cancer Biomarkers Market Analysis
        • 5.5.1 China Serum Cancer Biomarkers Production
        • 5.5.2 China Serum Cancer Biomarkers Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Serum Cancer Biomarkers Import and Export
      • 5.6 Japan Serum Cancer Biomarkers Market Analysis
        • 5.6.1 Japan Serum Cancer Biomarkers Production
        • 5.6.2 Japan Serum Cancer Biomarkers Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Serum Cancer Biomarkers Import and Export
      • 5.7 Southeast Asia Serum Cancer Biomarkers Market Analysis
        • 5.7.1 Southeast Asia Serum Cancer Biomarkers Production
        • 5.7.2 Southeast Asia Serum Cancer Biomarkers Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Serum Cancer Biomarkers Import and Export
      • 5.8 India Serum Cancer Biomarkers Market Analysis
        • 5.8.1 India Serum Cancer Biomarkers Production
        • 5.8.2 India Serum Cancer Biomarkers Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Serum Cancer Biomarkers Import and Export

      6 Serum Cancer Biomarkers Segment Market Analysis (by Type)

      • 6.1 Global Serum Cancer Biomarkers Production by Type
      • 6.2 Global Serum Cancer Biomarkers Revenue by Type
      • 6.3 Serum Cancer Biomarkers Price by Type

      7 Serum Cancer Biomarkers Segment Market Analysis (by Application)

      • 7.1 Global Serum Cancer Biomarkers Consumption by Application
      • 7.2 Global Serum Cancer Biomarkers Consumption Market Share by Application (2014-2019)

      8 Serum Cancer Biomarkers Major Manufacturers Analysis

      • 8.1 Roche
        • 8.1.1 Roche Serum Cancer Biomarkers Production Sites and Area Served
        • 8.1.2 Roche Product Introduction, Application and Specification
        • 8.1.3 Roche Serum Cancer Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Pfizer
        • 8.2.1 Pfizer Serum Cancer Biomarkers Production Sites and Area Served
        • 8.2.2 Pfizer Product Introduction, Application and Specification
        • 8.2.3 Pfizer Serum Cancer Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Novartis
        • 8.3.1 Novartis Serum Cancer Biomarkers Production Sites and Area Served
        • 8.3.2 Novartis Product Introduction, Application and Specification
        • 8.3.3 Novartis Serum Cancer Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Abbott
        • 8.4.1 Abbott Serum Cancer Biomarkers Production Sites and Area Served
        • 8.4.2 Abbott Product Introduction, Application and Specification
        • 8.4.3 Abbott Serum Cancer Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 BD
        • 8.5.1 BD Serum Cancer Biomarkers Production Sites and Area Served
        • 8.5.2 BD Product Introduction, Application and Specification
        • 8.5.3 BD Serum Cancer Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Merck
        • 8.6.1 Merck Serum Cancer Biomarkers Production Sites and Area Served
        • 8.6.2 Merck Product Introduction, Application and Specification
        • 8.6.3 Merck Serum Cancer Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Eli Lilly
        • 8.7.1 Eli Lilly Serum Cancer Biomarkers Production Sites and Area Served
        • 8.7.2 Eli Lilly Product Introduction, Application and Specification
        • 8.7.3 Eli Lilly Serum Cancer Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Agilent Technologies
        • 8.8.1 Agilent Technologies Serum Cancer Biomarkers Production Sites and Area Served
        • 8.8.2 Agilent Technologies Product Introduction, Application and Specification
        • 8.8.3 Agilent Technologies Serum Cancer Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Boehringer Ingelheim
        • 8.9.1 Boehringer Ingelheim Serum Cancer Biomarkers Production Sites and Area Served
        • 8.9.2 Boehringer Ingelheim Product Introduction, Application and Specification
        • 8.9.3 Boehringer Ingelheim Serum Cancer Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 AstraZeneca
        • 8.10.1 AstraZeneca Serum Cancer Biomarkers Production Sites and Area Served
        • 8.10.2 AstraZeneca Product Introduction, Application and Specification
        • 8.10.3 AstraZeneca Serum Cancer Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Bristol-Myers Squibb
      • 8.12 Novo Nordisk
      • 8.13 Allergan
      • 8.14 Gilead

      9 Development Trend of Analysis of Serum Cancer Biomarkers Market

      • 9.1 Global Serum Cancer Biomarkers Market Trend Analysis
        • 9.1.1 Global Serum Cancer Biomarkers Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Serum Cancer Biomarkers Regional Market Trend
        • 9.2.1 North America Serum Cancer Biomarkers Forecast 2019-2025
        • 9.2.2 Europe Serum Cancer Biomarkers Forecast 2019-2025
        • 9.2.3 China Serum Cancer Biomarkers Forecast 2019-2025
        • 9.2.4 Japan Serum Cancer Biomarkers Forecast 2019-2025
        • 9.2.5 Southeast Asia Serum Cancer Biomarkers Forecast 2019-2025
        • 9.2.6 India Serum Cancer Biomarkers Forecast 2019-2025
      • 9.3 Serum Cancer Biomarkers Market Trend (Product Type)
      • 9.4 Serum Cancer Biomarkers Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Serum Cancer Biomarkers Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Serum biomarkers are proteins generally detected in urine, blood, and other bodily fluids produced by malignant cells or in reaction to presence/absence of malignant cells. Preferably, biomarkers should have at least one or more than one of the following properties: prompt detection of cancer within high risk population, diagnosis of specific type of cancer, prediction in its growth, screen its treatment response, and detect early recurrence.
        The global serum cancer biomarkers market is projected to grow at a rapid pace in the next few years. Key drivers of the market are increase in the number of people suffering from different types of cancer and rise in the geriatric population. Increase in the cancer-afflicted population is anticipated to be another key driver of the market.

        The global Serum Cancer Biomarkers market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Serum Cancer Biomarkers volume and value at global level, regional level and company level. From a global perspective, this report represents overall Serum Cancer Biomarkers market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Serum Cancer Biomarkers in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Serum Cancer Biomarkers manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Roche
        Pfizer
        Novartis
        Abbott
        BD
        Merck
        Eli Lilly
        Agilent Technologies
        Boehringer Ingelheim
        AstraZeneca
        Bristol-Myers Squibb
        Novo Nordisk
        Allergan
        Gilead

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Hepatocellular Carcinoma Serum Biomarkers
        Lung Cancer Serum Biomarkers
        Pancreatic & Biliary Tract Cancer Serum Biomarkers
        Breast Cancer Serum Biomarkers
        Glioblastoma Serum Biomarkers
        Others

        Segment by Application
        Hospitals
        Academic & Research Institutes
        Ambulatory Surgical Centers
        Others

        Buy now